Biolevate selected as a Future 40 startup at STATION F, accelerating healthcare innovation with ethical AI.

Paris, France - 13 November 2024 - Biolevate, a pioneering company in biotechnology and healthcare innovation, is thrilled to announce its selection as one of the Future 40 startups at STATION F, the world's largest startup campus. This recognition places Biolevate in the top 4% of over 1,000 startups at the campus and underscores its commitment to transforming healthcare through ethical AI solutions.

Empowering healthcare innovation

Biolevate's mission is clear: to accelerate progress in healthcare by leveraging artificial intelligence for safe, efficient and compliant solutions. The company's flagship platform, ELISE (Elevate LIfe SciencE) uses advanced natural language processing (NLP) to streamline scientific documentation processes and ensure regulatory compliance in the life sciences.

"We are deeply humbled to be part of STATION F's Future 40," said Joël Belafa, CEO of Biolevate. "This recognition validates our efforts to bring innovative therapies to patients faster, while maintaining the highest standards of safety and compliance. At Biolevate, we believe that ethical AI can transform healthcare by reducing the time to market for new treatments and improving patient outcomes."

Accelerating growth and collaboration

Being part of the Future 40 cohort brings Biolevate unique visibility within the global startup ecosystem. This milestone opens doors to new partnerships, funding opportunities and talent acquisition as Biolevate continues its mission to drive meaningful change in healthcare.

Opportunities and partnerships

Biolevate's recognition as a Future 40 startup at STATION F opens up new prospects for the company. With this in mind, Biolevate will attend the upcoming AI for Health Summit on 21 November 2024.

This major event in the field of AI applied to healthcare will be an opportunity for the company to showcase its ELISE platform and exchange views with other industry leaders on the latest advances in AI for life sciences research, reinforcing Biolevate's commitment to remaining at the forefront of AI for Health innovation and actively engaging in discussions about the future of AI-assisted medical research.

About STATION F

STATION F is the world's largest startup campus, founded by Xavier Niel and based in Paris. The 50,000m² campus supports more than 1,000 startups per year through various programmes designed to foster growth and innovation. The Future 40 list highlights the top performing startups on the campus each year.

About Biolevate

Biolevate is a leading biotech company dedicated to transforming healthcare through innovative AI-driven solutions. Its flagship platform, ELISE Elevate LIfe SciencE), uses advanced natural language processing (NLP) to drive the creation and management of scientific documentation.

By accelerating regulatory compliance processes and reducing time-to-market by up to 30%, Biolevate enables life sciences companies to bring life-saving therapies to patients faster. With a strong focus on ethical AI and sustainability, Biolevate is committed to driving positive change in the life sciences sector.